Chugai Pharmaceutical Co., Ltd.

74
Buy
  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3519400000
JPY
7,434.00
-100 (-1.33%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationCash Flow
Chugai Pharmaceutical Co., Ltd. Cash flow Statement
Figures in Million
Consolidated Cash Flow Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
No of Months
12
12
12
12
12
12
Profit Before Tax
597,807.00
543,034.00
443,821.00
531,166.00
419,385.00
298,188.00
Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Changes In working Capital
-79,651.00
-28,843.00
130,634.00
-183,311.00
-83,122.00
-64,421.00
Cash Flow after changes in Working Capital
0.00
0.00
0.00
0.00
0.00
0.00
Cash Flow from Operating Activities
389,451.00
450,290.00
411,326.00
244,335.00
279,711.00
205,101.00
Cash Flow from Investing Activities
-204,873.00
-230,149.00
-38,772.00
-146,275.00
-119,060.00
-98,412.00
Cash Flow from Financing Activities
-307,457.00
-140,912.00
-139,250.00
-145,583.00
-107,360.00
-99,463.00
Net Cash Inflow / Outflow
-113,600.00
81,528.00
236,506.00
-45,584.00
55,419.00
8,392.00
Opening Cash & Cash Equivalents
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0.00
0.00
0.00
0.00
0.00
0.00
Cash & Cash Equivalent of Subsidiaries under liquidations
0.00
0.00
0.00
0.00
0.00
0.00
Translation adjustment on reserves / op cash balances foreign subsidiaries
0.00
0.00
0.00
0.00
0.00
0.00
Effect of Foreign Exchange Fluctuations
9,279.00
2,299.00
3,202.00
1,939.00
2,128.00
1,166.00
Closing Cash & Cash Equivalent
0.00
0.00
0.00
0.00
0.00
0.00
Figures in JPY Million
Seasonal companies are compared with the same quarter last year
Compare Cash Flow Results of Chugai Pharmaceutical Co., Ltd.
Markets Mojo
Figures in Million
consolidated Cash Flow Results
Markets Mojo
Markets Mojo
Change(JPY)
Change(%)
Profit Before Tax
597807
261919
3,35,888.00
128.24%
Adjustment
0
0
0.00
0.00%
Changes In working Capital
-79651
-128405
48,754.00
37.97%
Cash Flow after changes in Working Capital
0
0
0.00
0.00%
Cash Flow from Operating Activities
389451
77655
3,11,796.00
401.51%
Cash Flow from Investing Activities
-204873
-148241
-56,632.00
-38.20%
Cash Flow from Financing Activities
-307457
-97875
-2,09,582.00
-214.13%
Net Cash Inflow / Outflow
-113600
-150856
37,256.00
24.70%
Opening Cash & Cash Equivalents
0
0
0.00
0.00%
Cash & Cash Equivalent on Amalgamation / Take over / Merger
0
0
0.00
0.00%
Cash & Cash Equivalent of Subsidiaries under liquidations
0
0
0.00
0.00%
Translation adjustment on reserves / op cash balances foreign subsidiaries
0
0
0.00
0.00%
Effect of Foreign Exchange Fluctuations
9279
17605
-8,326.00
-47.29%
Closing Cash & Cash Equivalent
0
0
0.00
0.00%
Cash Flow - Snapshot (Consolidated) - Dec'25
stock-summary

YoY Growth in year ended Dec 2025 is -13.51% vs 9.47% in Dec 2024

Dec'25
Dec'24
Change(%)
Cash Flow from Operating Activities
3,89,451.00
4,50,290.00
-13.51%